Topic: AD

FDA approves anti-amyloid therapy for Alzheimer’s disease

August 17, 2023  

CNS effects of Wegovy (semaglutide)

February 28, 2023  

Targeting amyloid in AD – optimism amid controversy

January 15, 2020  

Pre-AAN Survey

March 27, 2019  

Two trials terminated in Alzheimer’s disease

January 31, 2019  

Third failed trial for solanezumab in AD

February 22, 2018  

IVIG: limited benefit in Alzheimer’s disease

August 2, 2017  

AAN 2017 DAILY REPORT

April 27, 2017  

Sun avoidance – more harm than good?

December 16, 2016  

Gum disease linked to cognitive decline in AD

December 7, 2016